Podcast | Intelligent Investment

We Go Together: Johnson & Johnson on biotech innovation, talent clusters and venture capital flows

August 22, 2023 38 Minute Listen

TWT Module S4E32

Talk to us

Melinda Richter, Johnson & Johnson’s Global Head of Innovation - JLABS, discusses finding, funding and incubating startups with expert market and sector commentary from CBRE’s Matt Gardner.

We Go Together: Johnson & Johnson on biotech innovation, talent clusters an...

August 22, 2023 38 Minute Listen

Every episode in your inbox

Unique insights on what matters most today in commercial real estate.

Key Takeaways:

  1. Biotech and life sciences companies tend to cluster together—for example, Boston or San Francisco have become ecosystems of innovation.
  2. Emerging markets like Atlanta present an early opportunity for investors to be a big fish in a small pond.
  3. “The most important fundamental in this business is the product pipeline. This year marks the first time the entire industry collectively has more than 12,000 products in phase two and phase three trials in the United States, almost a tenfold increase in 25 years. This spells long-term opportunity.” –Matt Gardner, Americas Life Sciences Leader, Advisory, CBRE


Photo of Melinda Richter

Melinda Richter

Global Head, Johnson & Johnson Innovation – JLABS

Melinda founded Johnson & Johnson Innovation – JLABS, the global incubator network of Johnson & Johnson Innovation, to connect early-stage companies to critical resources, expertise and community to support their success. JLABS is a global life science network for innovation, providing startups with access to capital-efficient lab space and resources, including expertise, community, industry connections and entrepreneurial programs. Of the more than 900 resident JLABS companies, 33% are female-led and 31% in the U.S. are minority-led, well above the industry average—demonstrating how important it is that the JLABS community reflects and speaks for the patients and global communities it hopes to serve. Before joining Johnson & Johnson, Melinda was Founder and CEO of Prescience International, an award-winning firm dedicated to accelerating research to the patient.

Photo of Matthew Gardner

Matthew Gardner

Americas Life Sciences Leader, Advisory, CBRE

Matt Gardner leads CBRE’s Advisory Life Sciences practice in the U.S., including occupier and investor leasing as well as sales. A veteran of more than 30 years in the technology and life sciences sectors, Mr. Gardner works with CBRE professionals across U.S. life sciences hubs and emerging markets to advise clients on their real estate needs. He is based in Northern California. Before joining CBRE, Mr. Gardner served as CEO and co-founder of the California Biomanufacturing Center. Mr. Gardner previously served as CEO of the life sciences cluster organizations BayBio and MarylandBio, supporting hundreds of growing life sciences companies in the process.


Photo of Spencer Levy

Spencer Levy

Global Client Strategist & Senior Economic Advisor, CBRE

Spencer Levy is Global Client Strategist and Senior Economic Advisor for CBRE, the largest commercial real estate services firm in the world. In this role, he focuses on client engagement and public-facing activities, including thought leadership work performed in conjunction with CBRE Research. He also serves as Co-Chair of the Real Estate Roundtable’s Research Committee.


Search All Episodes

Search and filter episodes by Industry and Property Type